Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma
Glioma is well known as the most aggressive and prevalent primary malignant tumor in the central nervous system. Molecular subtypes and prognosis biomarkers remain a promising research area of gliomas. Notably, the aberrant expression of mesenchymal (MES) subtype related long non-coding RNAs (lncRNA...
Main Authors: | Kebing Huang, Xiaoyu Yue, Yinfei Zheng, Zhengwei Zhang, Meng Cheng, Lianxin Li, Zhigang Chen, Zhihao Yang, Erbao Bian, Bing Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.726745/full |
Similar Items
-
Integrative analysis of a novel super-enhancer-associated lncRNA prognostic signature and identifying LINC00945 in aggravating glioma progression
by: Zhihao Yang, et al.
Published: (2023-03-01) -
A Novel Defined Endoplasmic Reticulum Stress-Related lncRNA Signature for Prognosis Prediction and Immune Therapy in Glioma
by: Yinfei Zheng, et al.
Published: (2022-06-01) -
Identification of an endoplasmic reticulum stress-related signature associated with clinical prognosis and immune therapy in glioma
by: Lianxin Li, et al.
Published: (2022-05-01) -
A Novel Defined Pyroptosis-Related Gene Signature for Predicting Prognosis and Treatment of Glioma
by: Zhihao Yang, et al.
Published: (2022-03-01) -
A Signature of Nine lncRNA Methylated Genes Predicts Survival in Patients With Glioma
by: Meng Cheng, et al.
Published: (2021-03-01)